These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 9369525)

  • 1. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease.
    Behl C
    Cell Tissue Res; 1997 Dec; 290(3):471-80. PubMed ID: 9369525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell signaling.
    Telerman A; Ofir R; Kashman Y; Elmann A
    BMC Complement Altern Med; 2017 Jun; 17(1):332. PubMed ID: 28645294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.
    Butterfield DA; Kanski J
    Peptides; 2002 Jul; 23(7):1299-309. PubMed ID: 12128086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease.
    Miranda S; Opazo C; Larrondo LF; Muñoz FJ; Ruiz F; Leighton F; Inestrosa NC
    Prog Neurobiol; 2000 Dec; 62(6):633-48. PubMed ID: 10880853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxidative stress and Alzheimer's disease].
    Liu XJ; Yang W; Qi JS
    Sheng Li Xue Bao; 2012 Feb; 64(1):87-95. PubMed ID: 22348966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.
    Chakrabarti S; Sinha M; Thakurta IG; Banerjee P; Chattopadhyay M
    Curr Med Chem; 2013; 20(37):4648-64. PubMed ID: 23834172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
    Butterfield DA; Reed T; Newman SF; Sultana R
    Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model.
    Drake J; Link CD; Butterfield DA
    Neurobiol Aging; 2003; 24(3):415-20. PubMed ID: 12600717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E and other antioxidants in neuroprotection.
    Behl C
    Int J Vitam Nutr Res; 1999 May; 69(3):213-9. PubMed ID: 10389030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of LOX and COX pathways via inhibition of amyloidogenesis contributes to mitoprotection against β-amyloid oligomer-induced toxicity in an animal model of Alzheimer's disease in rats.
    Kalra J; Kumar P; Majeed AB; Prakash A
    Pharmacol Biochem Behav; 2016; 146-147():1-12. PubMed ID: 27106205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
    Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
    Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease.
    Li J; Liu CN; Wei N; Li XD; Liu YY; Yang R; Jia YJ
    Brain Res; 2016 Jul; 1642():327-335. PubMed ID: 27071547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis.
    Silva CS; Eira J; Ribeiro CA; Oliveira Â; Sousa MM; Cardoso I; Liz MA
    Neurobiol Aging; 2017 Nov; 59():10-14. PubMed ID: 28780366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Abeta peptides in Alzheimer's disease.
    Tickler AK; Wade JD; Separovic F
    Protein Pept Lett; 2005 Aug; 12(6):513-9. PubMed ID: 16101387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro.
    Xie G; Tian W; Wei T; Liu F
    Free Radic Res; 2015 Feb; 49(2):139-50. PubMed ID: 25410532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.